These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 475360)

  • 21. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus.
    Moss B; Cooper N
    J Virol; 1982 Aug; 43(2):673-8. PubMed ID: 7109036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a herpesvirus saimiri-specified DNA polymerase activity which is aphidicolin-resistant and phosphonoacetate-sensitive.
    O'Hare P; Honess RW
    J Gen Virol; 1983 May; 64(Pt 5):1013-24. PubMed ID: 6302206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibition of human herpesvirus-6 by phosphonoformate.
    Streicher HZ; Hung CL; Ablashi DV; Hellman K; Saxinger C; Fullen J; Salahuddin SZ
    J Virol Methods; 1988 Sep; 21(1-4):301-4. PubMed ID: 2972736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and preliminary characterization of a phosphonoacetic acid-resistant and temperature-sensitive mutant of herpes simplex virus type 1.
    Daksis JI; Priemer MM; Chan VL
    J Virol; 1982 Apr; 42(1):20-9. PubMed ID: 6283139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxyribonucleic acid polymerase of wild-type and phosphonoacetic acid-resistant mutant of herpes simplex virus.
    Fridlender B; Chejanovsky N; Becker Y
    Antimicrob Agents Chemother; 1978 Jan; 13(1):124-7. PubMed ID: 204249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM; Furman PA; Gelep PT; Schaffer PA
    J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of phosphonoacetic acid-resistant mutants of human cytomegalovirus.
    D'Aquila RT; Summers WC
    J Virol; 1987 Apr; 61(4):1291-5. PubMed ID: 3029427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1.
    Jofre JT; Schaffer PA; Parris DS
    J Virol; 1977 Sep; 23(3):833-6. PubMed ID: 197275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J; Wahren B; Sundqvist VA; Levén B
    J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro effect of acyclovir and other antiherpetic compounds on the replication of channel catfish virus.
    Buck CC; Loh PC
    Antiviral Res; 1985 Oct; 5(5):269-80. PubMed ID: 2932997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of herpesvirus and human DNA polymerases by alpha-halogenated phosphonoacetates.
    McKenna CE; Khawli LA; Bapat A; Harutunian V; Cheng YC
    Biochem Pharmacol; 1987 Oct; 36(19):3103-6. PubMed ID: 3663227
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional and molecular characterization of African swine fever virus mutants resistant to phosphonoacetic acid.
    Marques MI; Costa JV
    Virology; 1995 Dec; 214(1):72-81. PubMed ID: 8525640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 40. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.